Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

House approves FDA appropriations

Executive Summary

As part of an agriculture appropriations package that includes $1.7 billion for FDA in fiscal 2008, House approves language barring the agency from spending any of the money to close any of its field labs or district offices. FDA's proposed reorganization has triggered an investigation by the House Energy and Commerce Committee Oversight Subcommittee. The panel's chairman, Bart Stupak, D-Mich., and full committee Chairman John Dingell, D-Mich., charge in a July 31 letter to Commissioner Andrew von Eschenbach that the agency has "failed to produce a credible rational" for the lab closings. The Senate will take up its appropriations bill when it returns from summer vacation in September (1"The Pink Sheet" July 23, 2007, p. 14)...

You may also be interested in...



DTC User Fees Rejected By House Approps Panel As FDA Safety Funds Get Boost

The House Appropriations Committee opted for using federal money, rather than fees from industry, to finance speedier FDA review of direct-to-consumer television ads when it approved a $1.7 billion fiscal year 2008 funding package for the agency July 19

Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines

Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS048647

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel